Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Tyrosine kinase inhibitor blocks choroidal neovascularization

May 4, 2004

Regression of ocular neovascularization by periocular PEDF gene therapy

May 4, 2004

CpG ODN 1826 activates uveitogenic T-cells in mice

May 4, 2004

Promising topical ciclosporin prodrug against corneal graft rejection

May 3, 2004

PKC-412 improves retinal volume and visual acuity in DME patients

May 3, 2004

Vaccines suggested as an alternative for treating glaucoma

April 30, 2004

Adjunctive therapy with lerdelimumab after phacotrabeculectomy beneficial for IOP

April 30, 2004

Curcumin effective against human retinal endothelial cell proliferation

April 30, 2004

IND clearance for squalamine in neovascular diseases of the eye

April 26, 2004

Phase II trial of INS-37217 Ophthalmic for rhegmatogenous retinal detachment

April 26, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...